Explore more Articles in

Stock Sectors

Are Markets Underpricing the Next Tariff Shock?

Economic activity appears set to strengthen in the official Q2 , but the second half of the year looks relatively vulnerable. One factor is...

Does Higher Dose Of Wegovy Result In More Weight Loss – Novo Nordisk (NYSE:NVO)

Novo Nordisk A/S NVO on Tuesday announced that it has submitted an application to the European Medicines Agency (EMA) for approval of a new,...

Why Is Penny Stock ProKidney Trading Higher On Tuesday? – ProKidney (NASDAQ:PROK)

ProKidney Corp. PROK stock is trading higher on Tuesday, with a session volume of 39.8 million compared to the average volume of 1.12 million...

US Dollar Regains Footing as Trump Shifts From Tariff Chaos to Control

Remember Trump’s Art of the ? It works. Two weeks ago, I noted that markets had reached "Peak Chaos" and that Trump’s tariff strategy would...

Oil Markets on Edge: Analyzing the 52% Risk of Hormuz Disruption

could rise all the way to $100 and more, peaking at $110 per barrel in case Iran closes the Strait of Hormuz, Goldman...

Oil Holds Ground on Fear, Not Fundamentals – All Eyes on Tehran’s Next Move

Oil prices retreat but remain supported driven by Israel-Iran tensions and fears over Strait of Hormuz disruptions. Crude’s rally stands in contrast to weak demand...

US Strikes on Iran Intensify Oil Supply Risks

Since the US targeted Iranian nuclear facilities over the weekend, supply risks for energy markets have increased significantly amid uncertainty about how Iran will...

US Strikes on Iran Push Oil Prices to 5-Month High

Oil prices surged to a five-month high following U.S. airstrikes on key Iranian nuclear facilities, sending shockwaves through global energy markets. The increase in...

Gold Falters Again at $3400 as Traders Shrug Off Geopolitical Risk

With off its highs and risk assets rebounding, gold’s muted response to Middle East tension is telling. Momentum is stalling and $3400 remains...

FDA Halts Trials Exporting Americans’ Cells To Hostile Countries For Genetic Engineering – CRISPR Therapeutics (NASDAQ:CRSP), Caribou Biosciences (NASDAQ:CRBU)

The U.S. Food and Drug Administration (FDA) on Wednesday initiated an immediate review of clinical trials that involved sending Americans’ living cells to China...

- A word from our sponsors -

Most Popular